LymphoDrain™ is currently under clinical investigation and it is not available on the market. The first version of LymphoDrain™ has been designed to treat arm lymphedema post breast cancer, and it is currently being used in the LymphoPilot Clinical Study at the University Hospital of Lausanne in Switzerland (CHUV), directed by Prof. Lucia Mazzolai.
The LymphoPilot Clinical Trial is a first-in-man study to assess feasibility and safety of the investigational implantable device LymphoPilot, and to collect preliminary data on lymphedema outcome measures.
CAUTION: LymphoDrain technology is under investigational use only and not available for commercial distribution.
2023 © COPYRIGHT – Lymphatica MEDTECH SA | Lausanne – Switzerland | PRIVACY POLICY | WEB & LOGO DESIGN
